Letter concerning “Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between ORR and median overall survival”: Toward surrogate endpoints for phase II trials in patients with recurrent glioblastoma
Journal article published in 2023 by
Vincenzo Di Nunno 
,
Lidia Gatto,
Alicia Tosoni,
Stefania Bartolini ,
Enrico Franceschi
,
Lidia Gatto,
Alicia Tosoni,
Stefania Bartolini ,
Enrico Franceschi
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 